Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

32 results about "Insertional mutagenesis" patented technology

In molecular biology, insertional mutagenesis is the creation of mutations of DNA by the addition of one or more base pairs. Such insertional mutations can occur naturally, mediated by viruses or transposons, or can be artificially created for research purposes in the lab.

Bacterial Mediated Delivery of Nuclear Protein Into Pluripotent and Differentiated Cells

A modified P. aeruginosa type III secretion system has been developed that efficiently delivers selected proteins into a host cell. In one example, a functional nuclear Cre Recombinase is injected into embryonic stem (ES) cells and can be used to induce pluripotent stem (iPS) cells. This method of in vitro lineage directed differentiation prevents insertional mutagenesis and provides a route to selected stem cell renewal and cell-based therapies.
Owner:UNIV OF FLORIDA RES FOUNDATION INC

Piggybac transposon variants and methods of use

InactiveUS20110311506A1Low integration rateSugar derivativesPeptide/protein ingredientsWild typeCabbage looper
The present invention provides hyperactive piggyBac transposons, in particular hyperactive piggyBac transposons from Trichoplusia ni (cabbage looper moth) that transpose at a higher frequency than wildtype. The invention also features integration defective piggyBac transposons. The piggyBac transposons and transposases can be used in gene transfer systems for stably introducing nucleic acids into the DNA of a cell. The gene transfer system can be used in methods, for example, but not limited to, gene therapy, insertional mutagenesis, or gene discovery.
Owner:THE JOHN HOPKINS UNIV SCHOOL OF MEDICINE

Enhanced nucleic acid constructs for eukaryotic gene expression

The present invention provides polynucleotide vectors for high expression of heterologous genes, and methods for constructing such vectors. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, but not limited to, gene expression, gene therapy, insertional mutagenesis, or gene discovery.
Owner:DNA2 0

Enhanced nucleic acid constructs for eukaryotic gene expression

The present invention provides polynucleotide vectors for high expression of heterologous genes, and methods for constructing such vectors. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, but not limited to, gene expression, gene therapy, insertional mutagenesis, or gene discovery.
Owner:DNA2 0

Enhanced nucleic acid constructs for eukaryotic gene expression

The present invention provides polynucleotide vectors for high expression of heterologous genes, and methods for constructing such vectors. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, but not limited to, gene expression, gene therapy, insertional mutagenesis, or gene discovery.
Owner:DNA2 0

Method For Genetic Selection Of High-Plasmid Producing E. Coli Clones

InactiveUS20090081681A1Increased IS insertional mutagenesisLow plasmid copy numberMicrobiological testing/measurementVector-based foreign material introductionProduction rateEscherichia coli
The present invention relates to methods of selecting for highly productive clones of E. coli for the production of plasmid DNA comprising measuring the frequency of IS1 transposon insertional mutagenesis within either the plasmid or genomic DNA of transformed clonal subtypes. An increase in IS1 insertional mutagenesis is correlated with clonal subtypes likely to exhibit a low specific productivity. The PCR-based, genetic selection assays disclosed herein are amenable to high throughput analysis, reducing the time to identify highly productive clones capable of cultivating large quantities of plasmid DNA on an industrial scale.
Owner:MERCK SHARP & DOHME CORP

Efficient transgenosis method with mediation of transcription activator-like effector protein

ActiveCN104651409ASimplify the process of experimentationImprove transgenic efficiencyMicroinjection basedFermentationTransgeneMicroinjection
The invention discloses an efficient transgenosis method with mediation of a transcription activator-like effector (TALE) protein. The method comprises the steps that a helper plasmid containing a transcription activator-like effector protein DNA (Deoxyribonucleic Acid) sequence and piggyBac transposon (PBase) DNA sequence is constructed by adopting a molecular biological technique, and transcribed to mRNA (Messenger Ribonucleic Acid) in vitro; mRNA of the helper plasmid and DNA of a piggyBac transposon plasmid containing an exogenous gene are imported to a fertilized egg of an animal by adopting a microinjection method; a transgenic animal of which the exogenous gene can be stably inherited and expresses is obtained; and a transgenosis positive individual is screened out according to a marker gene or the expression characteristic of the gene. With the adoption of the method, a piggyBac transposon can be efficiently inserted into a genome of a host organism by the action of a TALE-PBase fusion protein; the transgenosis efficiency mediated by the piggyBac transposon can be improved remarkably; and helps are offered to researches such as transgenic animal acquirement and insertion mutagenesis.
Owner:ZHEJIANG UNIV

Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias

The present invention provides polynucleotide vectors for high expression of heterologous genes. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, gene expression, bioprocessing, gene therapy, insertional mutagenesis, or gene discovery
Owner:DNA TWOPOINTO

Method for making insertional mutations

A method for making insertional mutations at random or quasi-random locations in the chromosomal or extra-chromosomal nucleic acid of a target cell includes the step of combining, in the target cell, cellular nucleic acid with a synaptic complex that comprises (a) a Tn5 transposase protein and (b) a polynucleotide that comprises a pair of nucleotide sequences adapted for operably interacting with Tn5 transposase and a transposable nucleotide sequence therebetween, under conditions that mediate transpositions into the cellular DNA. In the method, the synaptic complex is formed in vitro under conditions that disfavor or prevent the synaptic complexes from undergoing productive transposition.
Owner:WISCONSIN ALUMNI RES FOUND

Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois

The present invention provides polynucleotide vectors for high expression of heterologous genes. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, gene expression, bioprocessing, gene therapy, insertional mutagenesis, or gene discovery.
Owner:DNA TWOPOINTO

Enhanced nucleic acid constructs for eukaryotic gene expression

The present invention provides polynucleotide vectors for high expression of heterologous genes, and methods for constructing such vectors. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, but not limited to, gene expression, gene therapy, insertional mutagenesis, or gene discovery.
Owner:DNA2 0

Insertional mutagenesis technique

InactiveUS20040092018A1Without requiring costly and time-consuming genetic analysesWithout significant amountStable introduction of DNANucleic acid vectorInsertional mutagenesisViral vector
The inventon provides a method for producing a library of genetic mutations in a cell population by insertional mutagenesis, wherein a viral vector comprising a transposon is used to deliver said transposon to said cell population, which cell population stably expresses the cognate transposase for said transposon, and the transposon is mobilised to give a rise to the genetic mutations.
Owner:MINOS BIOSYST

DNA vectors, transposons and transposases for eukaryotic genome modification

The present invention provides polynucleotide vectors for high expression of heterologous genes. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, gene expression, bioprocessing, gene therapy, insertional mutagenesis, or gene discovery.
Owner:DNA2 0

Compositions and methods of using transposons

The present invention provides compositions and methods of using transposons. In one aspect, methods are disclosed that are useful for identifying negatively selected genes in an insertional mutagenesis screen. In another aspect, compositions for reducing proliferation of a tumor cell expressing an oncogenic RAS include an activator of a WNT pathway. Pharmaceutical compositions for reducing proliferation of tumor cells in a subject in need thereof by administering an effective amount of an activator of a WNT pathway to the tumor cells of the subject are also disclosed.
Owner:YALE UNIV

Method for converting pathogenic bacteria of pokkah boeng disease of sugarcane

PendingCN107746858AExtending Genetic Transformation ResearchImprove efficiencyMicroinjection basedMicroorganism based processesShootTrp operon
The invention discloses a method for transforming sugarcane tip rot pathogenic bacteria. The prepared spore suspension of sugarcane tip rot pathogen is evenly coated on a sterile filter membrane, and the expression cassette containing the fusion of tryptophan operon and hygromycin resistance gene is mixed with gold powder to form microprojectiles; Insertion mutants were obtained through resistance screening culture and molecular detection. The expression cassette used in the present invention is directly inserted to obtain mutants, and this method is easier to transform and obtain mutants.
Owner:GUANGXI UNIV

System for functional gene discovery in plants

The invention is directed to a method of multigenerational analysis of plants modified by insertional mutagenesis, and a method for associating plant mutant trait and genotype information. The invention is further directed to a method for managing data pertaining to plant mutant trait and genotype information in a database. The invention is further directed to a system for managing plant mutant trait and genotype information in a database, a system for allowing users to associate plant trait and genotype information, a system for facilitating business transactions with a user regarding plant materials or a gene sequence of interest to user and a computer-readable medium embodying a program of instructions for execution by a computer for implementing a system for allowing users to associate plant trait and genotype information.
Owner:AGRI GENETICS +1

DNA vectors and elements for sustained gene expression in eukaryotic cells

The present invention provides polynucleotide vectors for high expression of heterologous genes. Some vectors further comprise novel elements that further improve expression. The gene transfer systems can be used in methods, for example, gene expression, bioprocessing, gene therapy, insertional mutagenesis, or gene discovery.
Owner:DNA TWOPOINTO

Piggybac transposon variants and methods of use

The present invention provides hyperactive piggyBac transposons, in particular hyperactive piggyBac transposons from Trichoplusia ni (cabbage looper moth) that transpose at a higher frequency than wildtype. The invention also features integration defective piggyBac transposons. The piggyBac transposons and transposases can be used in gene transfer systems for stably introducing nucleic acids into the DNA of a cell. The gene transfer system can be used in methods, for example, but not limited to, gene therapy, insertional mutagenesis, or gene discovery.
Owner:THE JOHN HOPKINS UNIV SCHOOL OF MEDICINE

DNA vectors, transposons and transposases for eukaryotic genome modification

ActiveUS10233454B2Stably introducingHeterologous gene expression can be improvedPolypeptide with localisation/targeting motifMicroorganismsHeterologousGene transfer
The present invention provides polynucleotide vectors for high expression of heterologous genes. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, gene expression, bioprocessing, gene therapy, insertional mutagenesis, or gene discovery.
Owner:DNA TWOPOINTO

Compositions and methods of using transposons

The present invention provides compositions and methods of using transposons. In one aspect, methods are disclosed that are useful for identifying negatively selected genes in an insertional mutagenesis screen. In another aspect, compositions for reducing proliferation of a tumor cell expressing an oncogenic RAS include an activator of a WNT pathway. Pharmaceutical compositions for reducing proliferation of tumor cells in a subject in need thereof by administering an effective amount of an activator of a WNT pathway to the tumor cells of the subject are also disclosed.
Owner:YALE UNIV

Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias

The present invention provides polynucleotide vectors for high expression of heterologous genes. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, gene expression, bioprocessing, gene therapy, insertional mutagenesis, or gene discovery.
Owner:DNA TWOPOINTO

Dwarf gene in paddy rice

The rice dwarf gene relates to a rice gene, in particular to a rice dwarf gene obtained by T-DNA insertion mutation method. Provided are an osDw gene obtained by a method of T-DNA insertion mutation and its cloning method; an osDw gene RNAi expression vector and its construction method; a genetic transformation method of the osDw gene and its application in genetic transformation. The full length of the gene is 2720 bases, in which ATG at the 33rd to 35th is the start codon, and the TGA sequence at the 2253rd to 2255th is the stop codon. The cloning method is to amplify a 2.7kb nucleic acid fragment by PCR method based on the nucleic acid sequence published on NCBI based on the results of blast analysis; the nucleic acid fragment is recovered and confirmed by sequencing after being connected to the T carrier. It has the function of controlling the plant height of rice. The RNAi vector can be constructed according to its sequence, and dwarf plants can be obtained by transgenic method.
Owner:XIAMEN UNIV

Kit for preparing human body dopaminergic neurons and application thereof

The invention discloses a kit for preparing human body dopaminergic neurons and application thereof, and belongs to the field of biopharmacys. The kit comprises a fibroblast efficient separation culture solution, chemical modification mRNA, an induction culture solution, a small molecule compound induction combination 1 and an induction combination 2 for promoting maturation and survival. The invention also provides an application of the kit in reprogramming the skin fibroblasts of the Parkinson's patient to generate the dopaminergic neurons. According to the kit, the combination of cmRNA-ASLC1, cmRNA-LMX1A and cmRNA-NURR1 is generated by using the chemically modified mRNA (cmRNA) so as to directly reprogram the human fibroblasts into the dopamine nerve cells, the inherent risk of genome integration and insertion mutagenesis in the DNA method is eliminated by using the chemically modified mRNA (cmRNA), the transgenic tracer agent is not left, the small molecule combination is used to optimize the induction culture system. The generation efficiency and the maturity of the dopaminergic neurons are improved.
Owner:山东大学深圳研究院 +3

Compositions and Methods for Making Mutations in Cell Lines and Animals

The present invention is directed generally to reduction or inactivation of gene function or gene expression in cells in vitro and in multicellular organisms. The invention encompasses methods for mutating cells using a combination of mutagens, particularly wherein at least one mutagen is an insertional mutagen, to achieve homozygous gene mutation or mutation of multiple genes required cumulatively to achieve a phenotype to create knock-outs, knock-downs, and other modifications in the same cell. The invention is also directed to cells (and libraries thereof) and organisms created by the methods of the invention, including those in which at least one of the genes created by insertional mutagenesis is tagged by means of the insertion sequences thereby allowing identification of the mutated gene(s). The invention is also directed to libraries of mutated cells and their uses. The invention is also directed to methods of identifying mutations with methods of the invention, in cells (and libraries thereof) and organisms, by means of the insertional tag.
Owner:ABT HOLDING COMPANY

Method for genetic selection of high-plasmid producing e. coli clones

The present invention relates to methods of selecting for highly productive clones of E. coli for the production of plasmid DNA comprising measuring the frequency of IS1 transposon insertional mutagenesis within either the plasmid or genomic DNA of transformed clonal subtypes. An increase in IS1 insertional mutagenesis is correlated with clonal subtypes likely to exhibit a low specific productivity. The PCR-based, genetic selection assays disclosed herein are amenable to high throughput analysis, reducing the time to identify highly productive clones capable of cultivating large quantities of plasmid DNA on an industrial scale.
Owner:MERCK & CO INC

Compositions and methods for making mutations in cell lines and animals

The present invention is directed generally to reduction or inactivation of gene function or gene expression in cells in vitro and in multicellular organisms. The invention encompasses methods for mutating cells using a combination of mutagens, particularly wherein at least one mutagen is an insertional mutagen, to achieve homozygous gene mutation or mutation of multiple genes required cumulatively to achieve a phenotype to create knock-outs, knock-downs, and other modifications in the same cell. The invention is also directed to cells (and libraries thereof) and organisms created by the methods of the invention, including those in which at least one of the genes created by insertional mutagenesis is tagged by means of the insertion sequences thereby allowing identification of the mutated gene(s). The invention is also directed to libraries of mutated cells and their uses. The invention is also directed to methods of identifying mutations with methods of the invention, in cells (and libraries thereof) and organisms, by means of the insertional tag.
Owner:ABT HOLDING COMPANY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products